𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-lymphocyte therapy successfully controls late “cholestatic” rejection in pediatric liver transplant recipients

✍ Scribed by N. Kerkar; R. A. Morotti; K. Iyer; R. Arnon; T. Miloh; M. Sturdevant; F. Suchy; S. Florman; S. Emre

Book ID
110890570
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
213 KB
Volume
25
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histologic characteristics of late cellu
Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients
✍ Shikha S. Sundaram; Hector Melin-Aldana; Katie Neighbors; Estella M. Alonso 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Cellular rejection is a common event in orthotopic liver transplantation, leading to significant morbidity and mortality. Late acute cellular rejection, which occurs at least 3 months post-transplant, affects 8-32% of pediatric liver transplant recipients. The histopathology and clinical outcome of

Long-term outcome of mycophenolate mofet
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
✍ Marion Margaret Aw; Anita Verma; Mohamed Rela; Nigel Heaton; Giorgina Mieli-Verg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi